Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 66.96
(-1.18%)
INR 66.96
(-1.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -23.87 Million INR | -105.19% |
| 2022 | 459.62 Million INR | -3.56% |
| 2021 | 476.57 Million INR | 24.96% |
| 2020 | 381.37 Million INR | 524.83% |
| 2019 | 61.03 Million INR | 210.47% |
| 2018 | 19.65 Million INR | 354.68% |
| 2017 | -7.71 Million INR | 2.23% |
| 2016 | -7.89 Million INR | -882.36% |
| 2015 | -803.72 Thousand INR | -178.52% |
| 2014 | 1.02 Million INR | -6.55% |
| 2013 | 1.09 Million INR | 147.73% |
| 2012 | 442.13 Thousand INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 64.8 Million INR | -40.73% |
| 2023 Q4 | 109.33 Million INR | -19.57% |
| 2023 Q3 | 135.93 Million INR | -5.79% |
| 2023 Q1 | -413.43 Million INR | -610.39% |
| 2023 FY | -23.86 Million INR | -105.19% |
| 2023 Q2 | 144.28 Million INR | 134.9% |
| 2022 Q1 | 81 Million INR | -36.27% |
| 2022 FY | 459.62 Million INR | -3.56% |
| 2022 Q4 | 81 Million INR | -1.56% |
| 2022 Q3 | 82.28 Million INR | 119.9% |
| 2022 Q2 | -413.43 Million INR | -610.39% |
| 2021 Q3 | 121.79 Million INR | 1.04% |
| 2021 Q2 | 120.54 Million INR | 12.51% |
| 2021 Q4 | 127.1 Million INR | 4.36% |
| 2021 FY | 476.57 Million INR | 24.96% |
| 2021 Q1 | 107.13 Million INR | 28.19% |
| 2020 Q3 | 109.6 Million INR | 8.35% |
| 2020 FY | 381.37 Million INR | 524.83% |
| 2020 Q2 | 101.15 Million INR | 16.23% |
| 2020 Q4 | 83.57 Million INR | -23.75% |
| 2020 Q1 | 87.03 Million INR | 496.89% |
| 2019 Q4 | 14.58 Million INR | -41.06% |
| 2019 Q2 | 11.41 Million INR | 10.67% |
| 2019 Q1 | 10.31 Million INR | 49.99% |
| 2019 FY | 61.03 Million INR | 210.47% |
| 2019 Q3 | 24.73 Million INR | 116.81% |
| 2018 Q1 | -1.3 Million INR | 39.85% |
| 2018 FY | 19.65 Million INR | 354.68% |
| 2018 Q4 | 6.87 Million INR | -42.19% |
| 2018 Q3 | 11.89 Million INR | 441.54% |
| 2018 Q2 | 2.19 Million INR | 268.71% |
| 2017 Q2 | -3.45 Million INR | -422.9% |
| 2017 FY | -7.71 Million INR | 2.23% |
| 2017 Q4 | -2.16 Million INR | -52.53% |
| 2017 Q3 | -1.41 Million INR | 58.95% |
| 2017 Q1 | -660.91 Thousand INR | 90.14% |
| 2016 Q1 | -529.9 Thousand INR | -865.56% |
| 2016 FY | -7.89 Million INR | -882.36% |
| 2016 Q4 | -6.7 Million INR | -1740.7% |
| 2016 Q3 | -363.99 Thousand INR | -16.82% |
| 2016 Q2 | -311.59 Thousand INR | 41.2% |
| 2015 Q3 | -372 Thousand INR | -52.42% |
| 2015 Q2 | -244.06 Thousand INR | 19.8% |
| 2015 Q1 | -304.3 Thousand INR | -932.71% |
| 2015 FY | -803.72 Thousand INR | -178.52% |
| 2015 Q4 | 69.21 Thousand INR | 118.61% |
| 2014 Q3 | 807 Thousand INR | 0.0% |
| 2014 FY | 1.02 Million INR | -6.55% |
| 2014 Q4 | 36.54 Thousand INR | -95.47% |
| 2013 FY | 1.09 Million INR | 147.73% |
| 2012 FY | 442.13 Thousand INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|